Global Duvelisib Capsule Market Growth 2026-2032

September 2026 | 76 pages | ID: G3CD013E726EEN
LP Information

Abstracts

The global Duvelisib Capsule market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Treatment of adult patients with relapsed or refractory follicular lymphoma (r/r FL) who have received at least two prior systemic therapies.

United States market for Duvelisib Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Duvelisib Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Duvelisib Capsule is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Duvelisib Capsule players cover CSPC, Secura Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Duvelisib Capsule Industry Forecast” looks at past sales and reviews total world Duvelisib Capsule sales in 2025, providing a comprehensive analysis by region and market sector of projected Duvelisib Capsule sales for 2026 through 2032. With Duvelisib Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Duvelisib Capsule industry.

This Insight Report provides a comprehensive analysis of the global Duvelisib Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Duvelisib Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Duvelisib Capsule market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Duvelisib Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Duvelisib Capsule.

This report presents a comprehensive overview, market shares, and growth opportunities of Duvelisib Capsule market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 15mg
• 25mg

Segmentation by Application:

• Hospital
• Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• CSPC
• Secura Bio

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Duvelisib Capsule market?
• What factors are driving Duvelisib Capsule market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Duvelisib Capsule market opportunities vary by end market size?
• How does Duvelisib Capsule break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Duvelisib Capsule Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Duvelisib Capsule by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Duvelisib Capsule by Country/Region, 2021, 2025 & 2032
  2.2 Duvelisib Capsule Segment by Type
  2.2.1 15mg
  2.2.2 25mg
  2.2.3 Duvelisib Capsule Sales by Type
  2.2.3.1 Global Duvelisib Capsule Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Duvelisib Capsule Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Duvelisib Capsule Sale Price by Type (2021-2026)
  2.3 Duvelisib Capsule Segment by Application
  2.3.1 Hospital
  2.3.2 Pharmacy
  2.3.3 Duvelisib Capsule Sales by Application
  2.3.3.1 Global Duvelisib Capsule Sale Market Share by Application (2021-2026)
  2.3.3.2 Global Duvelisib Capsule Revenue and Market Share by Application (2021-2026)
  2.3.3.3 Global Duvelisib Capsule Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Duvelisib Capsule Breakdown Data by Company
  3.1.1 Global Duvelisib Capsule Annual Sales by Company (2021-2026)
  3.1.2 Global Duvelisib Capsule Sales Market Share by Company (2021-2026)
  3.2 Global Duvelisib Capsule Annual Revenue by Company (2021-2026)
  3.2.1 Global Duvelisib Capsule Revenue by Company (2021-2026)
  3.2.2 Global Duvelisib Capsule Revenue Market Share by Company (2021-2026)
  3.3 Global Duvelisib Capsule Sale Price by Company
  3.4 Key Manufacturers Duvelisib Capsule Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Duvelisib Capsule Product Location Distribution
  3.4.2 Players Duvelisib Capsule Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DUVELISIB CAPSULE BY GEOGRAPHIC REGION

  4.1 World Historic Duvelisib Capsule Market Size by Geographic Region (2021-2026)
  4.1.1 Global Duvelisib Capsule Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Duvelisib Capsule Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Duvelisib Capsule Market Size by Country/Region (2021-2026)
  4.2.1 Global Duvelisib Capsule Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Duvelisib Capsule Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Duvelisib Capsule Sales Growth
  4.4 APAC Duvelisib Capsule Sales Growth
  4.5 Europe Duvelisib Capsule Sales Growth
  4.6 Middle East & Africa Duvelisib Capsule Sales Growth

5 AMERICAS

  5.1 Americas Duvelisib Capsule Sales by Country
  5.1.1 Americas Duvelisib Capsule Sales by Country (2021-2026)
  5.1.2 Americas Duvelisib Capsule Revenue by Country (2021-2026)
  5.2 Americas Duvelisib Capsule Sales by Type (2021-2026)
  5.3 Americas Duvelisib Capsule Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Duvelisib Capsule Sales by Region
  6.1.1 APAC Duvelisib Capsule Sales by Region (2021-2026)
  6.1.2 APAC Duvelisib Capsule Revenue by Region (2021-2026)
  6.2 APAC Duvelisib Capsule Sales by Type (2021-2026)
  6.3 APAC Duvelisib Capsule Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Duvelisib Capsule by Country
  7.1.1 Europe Duvelisib Capsule Sales by Country (2021-2026)
  7.1.2 Europe Duvelisib Capsule Revenue by Country (2021-2026)
  7.2 Europe Duvelisib Capsule Sales by Type (2021-2026)
  7.3 Europe Duvelisib Capsule Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Duvelisib Capsule by Country
  8.1.1 Middle East & Africa Duvelisib Capsule Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Duvelisib Capsule Revenue by Country (2021-2026)
  8.2 Middle East & Africa Duvelisib Capsule Sales by Type (2021-2026)
  8.3 Middle East & Africa Duvelisib Capsule Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Duvelisib Capsule
  10.3 Manufacturing Process Analysis of Duvelisib Capsule
  10.4 Industry Chain Structure of Duvelisib Capsule

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Duvelisib Capsule Distributors
  11.3 Duvelisib Capsule Customer

12 WORLD FORECAST REVIEW FOR DUVELISIB CAPSULE BY GEOGRAPHIC REGION

  12.1 Global Duvelisib Capsule Market Size Forecast by Region
  12.1.1 Global Duvelisib Capsule Forecast by Region (2027-2032)
  12.1.2 Global Duvelisib Capsule Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Duvelisib Capsule Forecast by Type (2027-2032)
  12.7 Global Duvelisib Capsule Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 CSPC
  13.1.1 CSPC Company Information
  13.1.2 CSPC Duvelisib Capsule Product Portfolios and Specifications
  13.1.3 CSPC Duvelisib Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 CSPC Main Business Overview
  13.1.5 CSPC Latest Developments
  13.2 Secura Bio
  13.2.1 Secura Bio Company Information
  13.2.2 Secura Bio Duvelisib Capsule Product Portfolios and Specifications
  13.2.3 Secura Bio Duvelisib Capsule Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Secura Bio Main Business Overview
  13.2.5 Secura Bio Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Duvelisib Capsule Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Duvelisib Capsule Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 15mg
Table 4. Major Players of 25mg
Table 5. Global Duvelisib Capsule Sales by Type (2021-2026) & (K Units)
Table 6. Global Duvelisib Capsule Sales Market Share by Type (2021-2026)
Table 7. Global Duvelisib Capsule Revenue by Type (2021-2026) & ($ million)
Table 8. Global Duvelisib Capsule Revenue Market Share by Type (2021-2026)
Table 9. Global Duvelisib Capsule Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Duvelisib Capsule Sale by Application (2021-2026) & (K Units)
Table 11. Global Duvelisib Capsule Sale Market Share by Application (2021-2026)
Table 12. Global Duvelisib Capsule Revenue by Application (2021-2026) & ($ million)
Table 13. Global Duvelisib Capsule Revenue Market Share by Application (2021-2026)
Table 14. Global Duvelisib Capsule Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Duvelisib Capsule Sales by Company (2021-2026) & (K Units)
Table 16. Global Duvelisib Capsule Sales Market Share by Company (2021-2026)
Table 17. Global Duvelisib Capsule Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Duvelisib Capsule Revenue Market Share by Company (2021-2026)
Table 19. Global Duvelisib Capsule Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Duvelisib Capsule Producing Area Distribution and Sales Area
Table 21. Players Duvelisib Capsule Products Offered
Table 22. Duvelisib Capsule Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Duvelisib Capsule Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Duvelisib Capsule Sales Market Share Geographic Region (2021-2026)
Table 27. Global Duvelisib Capsule Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Duvelisib Capsule Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Duvelisib Capsule Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Duvelisib Capsule Sales Market Share by Country/Region (2021-2026)
Table 31. Global Duvelisib Capsule Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Duvelisib Capsule Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Duvelisib Capsule Sales by Country (2021-2026) & (K Units)
Table 34. Americas Duvelisib Capsule Sales Market Share by Country (2021-2026)
Table 35. Americas Duvelisib Capsule Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Duvelisib Capsule Sales by Type (2021-2026) & (K Units)
Table 37. Americas Duvelisib Capsule Sales by Application (2021-2026) & (K Units)
Table 38. APAC Duvelisib Capsule Sales by Region (2021-2026) & (K Units)
Table 39. APAC Duvelisib Capsule Sales Market Share by Region (2021-2026)
Table 40. APAC Duvelisib Capsule Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Duvelisib Capsule Sales by Type (2021-2026) & (K Units)
Table 42. APAC Duvelisib Capsule Sales by Application (2021-2026) & (K Units)
Table 43. Europe Duvelisib Capsule Sales by Country (2021-2026) & (K Units)
Table 44. Europe Duvelisib Capsule Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Duvelisib Capsule Sales by Type (2021-2026) & (K Units)
Table 46. Europe Duvelisib Capsule Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Duvelisib Capsule Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Duvelisib Capsule Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Duvelisib Capsule Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Duvelisib Capsule Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Duvelisib Capsule
Table 52. Key Market Challenges & Risks of Duvelisib Capsule
Table 53. Key Industry Trends of Duvelisib Capsule
Table 54. Duvelisib Capsule Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Duvelisib Capsule Distributors List
Table 57. Duvelisib Capsule Customer List
Table 58. Global Duvelisib Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Duvelisib Capsule Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Duvelisib Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Duvelisib Capsule Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Duvelisib Capsule Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Duvelisib Capsule Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Duvelisib Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Duvelisib Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Duvelisib Capsule Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Duvelisib Capsule Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Duvelisib Capsule Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Duvelisib Capsule Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Duvelisib Capsule Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Duvelisib Capsule Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. CSPC Basic Information, Duvelisib Capsule Manufacturing Base, Sales Area and Its Competitors
Table 73. CSPC Duvelisib Capsule Product Portfolios and Specifications
Table 74. CSPC Duvelisib Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. CSPC Main Business
Table 76. CSPC Latest Developments
Table 77. Secura Bio Basic Information, Duvelisib Capsule Manufacturing Base, Sales Area and Its Competitors
Table 78. Secura Bio Duvelisib Capsule Product Portfolios and Specifications
Table 79. Secura Bio Duvelisib Capsule Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Secura Bio Main Business
Table 81. Secura Bio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Duvelisib Capsule
Figure 2. Duvelisib Capsule Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Duvelisib Capsule Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Duvelisib Capsule Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Duvelisib Capsule Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Duvelisib Capsule Sales Market Share by Country/Region (2025)
Figure 10. Duvelisib Capsule Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 15mg
Figure 12. Product Picture of 25mg
Figure 13. Global Duvelisib Capsule Sales Market Share by Type in 2026
Figure 14. Global Duvelisib Capsule Revenue Market Share by Type (2021-2026)
Figure 15. Duvelisib Capsule Consumed in Hospital
Figure 16. Global Duvelisib Capsule Market: Hospital (2021-2026) & (K Units)
Figure 17. Duvelisib Capsule Consumed in Pharmacy
Figure 18. Global Duvelisib Capsule Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Global Duvelisib Capsule Sale Market Share by Application (2025)
Figure 20. Global Duvelisib Capsule Revenue Market Share by Application in 2026
Figure 21. Duvelisib Capsule Sales by Company in 2026 (K Units)
Figure 22. Global Duvelisib Capsule Sales Market Share by Company in 2026
Figure 23. Duvelisib Capsule Revenue by Company in 2026 ($ millions)
Figure 24. Global Duvelisib Capsule Revenue Market Share by Company in 2026
Figure 25. Global Duvelisib Capsule Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Duvelisib Capsule Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Duvelisib Capsule Sales 2021-2026 (K Units)
Figure 28. Americas Duvelisib Capsule Revenue 2021-2026 ($ millions)
Figure 29. APAC Duvelisib Capsule Sales 2021-2026 (K Units)
Figure 30. APAC Duvelisib Capsule Revenue 2021-2026 ($ millions)
Figure 31. Europe Duvelisib Capsule Sales 2021-2026 (K Units)
Figure 32. Europe Duvelisib Capsule Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Duvelisib Capsule Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Duvelisib Capsule Revenue 2021-2026 ($ millions)
Figure 35. Americas Duvelisib Capsule Sales Market Share by Country in 2026
Figure 36. Americas Duvelisib Capsule Revenue Market Share by Country (2021-2026)
Figure 37. Americas Duvelisib Capsule Sales Market Share by Type (2021-2026)
Figure 38. Americas Duvelisib Capsule Sales Market Share by Application (2021-2026)
Figure 39. United States Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Duvelisib Capsule Sales Market Share by Region in 2026
Figure 44. APAC Duvelisib Capsule Revenue Market Share by Region (2021-2026)
Figure 45. APAC Duvelisib Capsule Sales Market Share by Type (2021-2026)
Figure 46. APAC Duvelisib Capsule Sales Market Share by Application (2021-2026)
Figure 47. China Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 51. India Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Duvelisib Capsule Sales Market Share by Country in 2026
Figure 55. Europe Duvelisib Capsule Revenue Market Share by Country (2021-2026)
Figure 56. Europe Duvelisib Capsule Sales Market Share by Type (2021-2026)
Figure 57. Europe Duvelisib Capsule Sales Market Share by Application (2021-2026)
Figure 58. Germany Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 59. France Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Duvelisib Capsule Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Duvelisib Capsule Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Duvelisib Capsule Sales Market Share by Application (2021-2026)
Figure 66. Egypt Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Duvelisib Capsule Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Duvelisib Capsule in 2026
Figure 72. Manufacturing Process Analysis of Duvelisib Capsule
Figure 73. Industry Chain Structure of Duvelisib Capsule
Figure 74. Channels of Distribution
Figure 75. Global Duvelisib Capsule Sales Market Forecast by Region (2027-2032)
Figure 76. Global Duvelisib Capsule Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Duvelisib Capsule Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Duvelisib Capsule Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Duvelisib Capsule Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Duvelisib Capsule Revenue Market Share Forecast by Application (2027-2032)